首页> 美国政府科技报告 >Assessment of GPR30, a Seven Transmembrane-spanning Estrogen Receptor, as an Oncogene
【24h】

Assessment of GPR30, a Seven Transmembrane-spanning Estrogen Receptor, as an Oncogene

机译:评估GpR30,一种跨越七跨膜的雌激素受体,作为致癌基因

获取原文

摘要

Expression of the seven transmembrane-spanning receptor (7TMR), GPR30, in primary human breast tumors is positively associated with several tumor progression variables including extra mammary metastases (Filardo et al, 2006). Altered expression of 7TMRs is linked with a spectrum of disease phenotypes, including cancer, raising the possibility that GPR30 may function as an oncogene. Prior attempts to construct transgenic mice capable of expressing (HA-GPR30) transgenes under the transcriptional control of the mouse mammary tumor virus (MMTV) promoter failed. A second no cost extension was requested to construct mice with an HA-GPR30 transgene regulated by the whey acidic protein(WAP) promoter. These mice have recently been constructed and their genotypic and phenotypic analysis is underway.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号